e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury
Geudens N., Van de Wouwer M., Vanaudenaerde B. M., Vos R., Van De Wauwer C., Verleden G. M., Verbeken E., Lerut T., Van Raemdonck D. E. M., Conway E. M.
Source:
Eur Respir J 2008; 32: 862-870
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Geudens N., Van de Wouwer M., Vanaudenaerde B. M., Vos R., Van De Wauwer C., Verleden G. M., Verbeken E., Lerut T., Van Raemdonck D. E. M., Conway E. M.. The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury. Eur Respir J 2008; 32: 862-870
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
The lectin-like domain of thrombomodulin supresses leukocyte lung infiltration in a murine ischemia-reperfusion injury model
Source: Eur Respir J 2006; 28: Suppl. 50, 779s
Year: 2006
Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Human protein C concentrate administration reduces inflammation and apoptosis in lung after experimental sepsis
Source: Eur Respir J 2005; 26: Suppl. 49, 461s
Year: 2005
Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
Desferrioxamine attenuates minor lung injury following surgical acute liver failure
Source: Eur Respir J 2009; 33: 1429-1436
Year: 2009
Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation
Source: Eur Respir J 2007; 30: 423-428
Year: 2007
Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury
Source: Eur Respir J 2013; 41: 165-176
Year: 2013
Post-treatment with the heat shock protein 90 (hsp90) inhibitor, AUY-922, reduces lung hsp90 tyrosine (Y) phosphorylation and pulmonary inflammation in LPS-induced acute lung injury (ALI) in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Kallistatin protects against LPS-induced mouse lung injury
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation
Source: Eur Respir J 2011; 37: 925-932
Year: 2011
Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury
Source: Eur Respir J 2009; 33: 1415-1428
Year: 2009
Inhaled activated protein C protects mice from ventilator-induced lung injury
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009
Dose-response of the lectin-like domain of TNF on lung oedema and lung mechanics in isolated rat lungs subjected to LPS-induced lung injury
Source: Eur Respir J 2006; 28: Suppl. 50, 348s
Year: 2006
Intermedin stabilized endothelial barrier function and attenuated ventilator-induced lung injury in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Endothelial- but not leukocytic-NOX2 mediates vascular injury in ischemia/reperfusion syndrome of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006
Bone morphogenetic protein 9 protects against neonatal hyperoxia-induced impairment of lung development, inflammation and fibrosis.
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017
A role for PAR1 in lipopolysaccharide induced acute lung injury
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept